Publications by authors named "P Zaoui"

Claim this Profile
E
Expert perspectives on incorporating glucagon-like peptide-1 receptor agonist in diabetes and chronic kidney disease: challenges and opportunities.
Jean-Michel Halimi, Laurent Fauchier, Alexandre Karras, Chloé Amouyal, Dominique Eladari, Philippe Zaoui

Eur J Prev Cardiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the BIOGROUP French laboratories database to conduct CKD observational studies: a pilot EPI-CKD1 study.
Claire Visseaux, Guillaume Pénaranda, Cécile Conte, Fanny Raguideau, Julien L'hirondel, Philippe Zaoui

Clin Chem Lab Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective Study.
Caroline Arches, Arwa Jalal-Eddine, Dimitri Titeca-Beauport, Myriam Dao, Thierry Lobbedez, Philippe Zaoui

Kidney Int Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation.
Marion Cremoni, Maxime Teisseyre, Olivier Thaunat, Céline Fernandez, Christine Payre, Philippe Zaoui

Kidney Int Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.
Brad H Rovin, Pierre M Ronco, Jack F M Wetzels, Sharon G Adler, Isabelle Ayoub, Philippe Zaoui

Kidney Int Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis